Interaction of splenectomy and perioperative blood transfusions on prognosis of patients with proximal gastric and gastroesophageal junction cancer

Journal of Clinical Oncology

Volumn 21, Issue 24, 2003, Pages 4597-4603

  Weitz, Jürgen ^a   D'Angelica, Michael ^a   Gonen, Mithat ^a   Klimstra, David ^a   Coit, Daniel G ^a   Brennan, Murray F ^a   Karpeh, Martin S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS SURGERY; FOLLOW UP; HUMAN; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SPLENECTOMY; STOMACH CANCER; STOMACH SURGERY; ADENOCARCINOMA; ADULT; AGED; CHI SQUARE DISTRIBUTION; FEMALE; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; STATISTICS; STOMACH TUMOR; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SPLENECTOMY; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1542753572     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.12.136     Document Type: Article

References (40)

1. Jemal A, Thomas A, Murray T, et al: Cancer Statistics. CA Cancer J Clin 52:23-47, 2002
2. Karpeh M, Leon L, Klimstra D, et al: Lymph node staging in gastric cancer: Is location more important than number? Ann Surg 232:362-371, 2000
3. Cuschieri A, Weeden S, Fielding J, et al: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Br J Cancer 79:1522-1530, 1999
4. Bonenkamp JJ, Hermans J, Sasako M, et al: Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908-914, 1999
5. Csendes A, Burdiles P, Rojas J, et al: A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 131:401-407, 2002
6. Llende M, Santiago-Delpin EA, Lavergne J: Immunobiological consequences of splenectomy: A review. J Surg Res 40:85-94, 1986
7. Griffith JP, Sue-Ling HM, Dixon MI, et al: Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 36:684-690, 1995
8. Wanebo HJ, Kennedy BJ, Winchester DP, et al: Role of splenectomy in gastric cancer surgery: Adverse effect of elective splenectomy on long-term survival. J Am Coll Surg 185:177-184, 1997
9. Maeta M, Shimizu N, Oka A, et al: Perioperative allogeneic blood transfusion exacerbates surgical stress-induced postoperative immunosuppression and has a negative effect on prognosis in patients with gastric cancer. J Surg Oncol 55:149-153, 1994
10. Hyung WJ, Noh SH, Shin DW, et al: Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol 9:5-12, 2002
11. Fong Y, Karpeh M, Mayer K, et al: Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 167:256-260, 1994
12. Dhar DK, Kubota H, Tachibana M, et al: A tailored perioperative blood transfusion might avoid undue recurrences in gastric carcinoma patients. Dig Dis Sci 45:1737-1742, 2000
13. Marquet RL, Heineman E, Tank B, et al: Abrogation of the beneficial blood transfusion effect in dogs by splenectomy. World J Surg 8:408-413, 1984
14. Shelby J, Wakley E, Corry RJ: Suppressor cell induction in donor-specific transfused mouse heart recipients: Surgery 96:296-301, 1984
15. Shelby J, Wakley E, Corry RJ: Splenectomy abrogates the improved graft survival achieved by donor-specific transfusion. Transplant Proc 17:1083-1086, 1985
16. Yamaguchi Y, Goto M, Makino Y, et al: Prolonged survival of rat hepatic allografts pretreated with single donor-specific blood transfusion: The distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient. J Surg Res 61:23-29, 1996
17. Brady MS, Rogatko A, Dent L, et al: Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma. Arch Surg 126:359-364, 1991
18. Cuschieri A, Fayers P, Fielding J, et al: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: Preliminary results of the MRC randomised controlled surgical trial. Lancet 347:995-999, 1996
19. Monig SP, Collet PH, Baldus SE, et al: Splenectomy in proximal gastric cancer: Frequency of lymph node metastasis to the splenic hilus. J Surg Oncol 76:89-92, 2001
20. Kitamura K, Nishida S, Yamamoto K, et al: Lymph node metastasis in gastric cancer in the upper third of the stomach: Surgical treatment on the basis of the anatomical distribution of positive node. Hepatogastroenterology 45:281-285, 1998
21. Sakaguchi T, Sawada H, Yamada Y, et al: Indication for splenectomy for gastric carcinoma involving the proximal part of the stomach. Hepatogastroenterology 48:603-605, 2001
22. Siewert JR, Stein HJ: Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85:1457-1459, 1998
23. Sobin LH, Wittekind C: UICC: TNM Classification of Malignant Tumors. London, United Kingdom, John Wiley & Sons, 1997
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
25. Cox DR: Regression models and life-tables. J R Stat Soc (B) 34:187-220, 1972
26. Siewert JR, Feith M, Werner M, et al: Adenocarcinoma of the esophagogastric junction. Ann Surg 232:353-361, 2000
27. Dresner SM, Lamb PJ, Bennett MK, et al: The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 129:103-109, 2001
28. Brunson ME, Alexander JW: Mechanisms of transfusion-induced immunosuppression. Transfusion 30:651-658, 1990
29. Opelz G, Sengar DPS, Mickey MR, et al: Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 5:253-259, 1973
30. Blajchman MA, Bardossy L, Carmen R, et al: Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leukodepletion and passive transfer using spleen cells. Blood 81:1880-1882, 1993
31. Banowsky LH, Saunders P, Riehl B, et al: Effect of pretransplant blood transfusions and splenectomy on renal allograft survival in the Lewis rat. J Urol 130:996-998, 1983
32. Martin RC, Jaques DP, Brennan MF, et al: Extended local resection for advanced gastric cancer: Increased survival versus increased morbidity. Ann Surg 236:159-165, 2002
33. Saji S, Sakamoto J, Teramukai S, et al: Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: Covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system-Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer. Surg Today 29:504-510, 1999
34. Okuno K, Tanaka A, Shigeoka H, et al: Suppression of T-cell function in gastric cancer patients after total gastrectomy with splenectomy: Implications of splenic autotransplantation. Gastric Cancer 2:20-25, 1999
35. Sy MS, Miller SD, Kowach HB, et al: A splenic requirement for the generation of suppressor T cells. J Immunol 119:2095-2099, 1977
36. Heiss MM, Simon EH, Beyer BCM, et al: Minimal residual disease in gastric cancer: Evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow. J Clin Oncol 20:2005-2016, 2002
37. Heiss MM, Allgayer H, Gruetzner KU, et al: Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer. Nat Med 1:1035-1039, 1995
38. Kienle P, Koch M: Minimal residual disease in gastrointestinal cancer. Semin Surg Oncol 20:282-293, 2001
39. Heiss MM, Allgayer H, Gruetzner KU, et al: Prognostic influence of blood transfusion on minimal residual disease in resected gastric cancer patients. Anticancer Res 17:2657-2662, 1997
40. Sano T, Yamamoto S, Sasako M: Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan clinical oncology group study JCOG 0110-MF. Jpn J Clin Oncol 32:363-364, 2002